2025 annual financial data
Vir Biotechnology 2025 Operating margin
Vir Biotechnology 2025 operating margin with verified reported values.
Direct answer
Operating margin was -682.68%.
Operating income was -468,020,000 USD and net income was -437,987,000 USD.
Operating cash flow was -391,781,000 USD.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 68,556,000 USD
- Operating income
- -468,020,000 USD
- Net income
- -437,987,000 USD
- Operating cash flow
- -391,781,000 USD